» Articles » PMID: 12586828

Role of Histone Methyltransferase G9a in CpG Methylation of the Prader-Willi Syndrome Imprinting Center

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2003 Feb 15
PMID 12586828
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Imprinted genes in mammals are often located in clusters whose imprinting is subject to long range regulation by cis-acting sequences known as imprinting centers (ICs). The mechanisms by which these ICs exert their effects is unknown. The Prader-Willi syndrome IC (PWS-IC) on human chromosome 15 and mouse chromosome 7 regulates imprinted gene expression bidirectionally within an approximately 2-megabase region and shows CpG methylation and histone H3 Lys-9 methylation in somatic cells specific for the maternal chromosome. Here we show that histone H3 Lys-9 methylation of the PWS-IC is reduced in mouse embryonic stem (ES) cells lacking the G9a histone H3 Lys-9/Lys-27 methyltransferase and that maintenance of CpG methylation of the PWS-IC in mouse ES cells requires the function of G9a. We show by RNA fluorescence in situ hybridization (FISH) that expression of Snrpn, an imprinted gene regulated by the PWS-IC, is biallelic in G9a -/- ES cells, indicating loss of imprinting. By contrast, Dnmt1 -/- ES cells lack CpG methylation of the PWS-IC but have normal levels of H3 Lys-9 methylation of the PWS-IC and show normal monoallelic Snrpn expression. Our results demonstrate a role for histone methylation in the maintenance of parent-specific CpG methylation of imprinting regulatory regions and suggest a possible role of histone methylation in establishment of these CpG methylation patterns.

Citing Articles

EHMT2 as a Candidate Gene for an Autosomal Recessive Neurodevelopmental Syndrome.

Carvalho L, Rzasa J, Kerkhof J, McConkey H, Fishman V, Koksharova G Mol Neurobiol. 2024; .

PMID: 39674972 DOI: 10.1007/s12035-024-04655-x.


Roles of chromatin and genome instability in cellular senescence and their relevance to ageing and related diseases.

Wu Z, Qu J, Liu G Nat Rev Mol Cell Biol. 2024; 25(12):979-1000.

PMID: 39363000 DOI: 10.1038/s41580-024-00775-3.


Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome.

Wang S, Cheng Y, Lim J, Jang M, Forrest E, Kim Y Res Sq. 2024; .

PMID: 39011107 PMC: 11247926. DOI: 10.21203/rs.3.rs-4530649/v1.


Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome.

Wang S, Xiong Y, Jang M, Park K, Donahue M, Velez J Mol Ther. 2024; 32(8):2662-2675.

PMID: 38796700 PMC: 11405540. DOI: 10.1016/j.ymthe.2024.05.034.


Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation.

Tibben B, Rothbart S J Mol Biol. 2023; 436(7):168394.

PMID: 38092287 PMC: 10957332. DOI: 10.1016/j.jmb.2023.168394.